MoneyWorks4Me

Shukra Pharmaceuticals informs about compliances-certificate

07 Oct 2023 Evaluate
Shukra Pharmaceuticals has enclosed the Certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 by Purva Sharegistry (India), the Registrar and Share Transfer Agent (RTA) of the Company, confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the second quarter ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..